Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2024

Accrued Liabilities and Other Liabilities [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Marketing reimbursement	$	2,031	$	2,834
Accrued compensation		2,752		1,687
Accrued clinical trials and R&D		4,549		3,694
Accrued selling and marketing		845		1,110
Accrued professional fees		1,152		1,505
Accrued warranty		21		44
Accrued restructuring		8		655
Other accrued expenses		3,148		3,966
Total accrued expenses and other current liabilities	$	14,506	$	15,495